多瑞医药：王庆太、曹晓兵要约收购期满 公司股票将于2026年2月27日复牌

Group 1 - The company's stock will resume trading on February 27, 2026 [1] - During the tender offer period from January 22, 2026, to February 24, 2026, shareholder accounts that accepted the offer totaled 3, with a total of 17.60 million shares accepted by Wang Qingtai [1] - Another 4 shareholder accounts accepted the offer from Cao Xiaobing, totaling 1.85 million shares [1] Group 2 - After the completion of the tender offer, the acquirer and its concert parties will hold a total of 43.12 million shares in the company, representing 53.90% of the total share capital [1]